92 related articles for article (PubMed ID: 33425930)
1. A Systematic Review and Meta-Analysis of Health Utility Estimates in Chronic Spontaneous Urticaria.
Yuan Y; Xiao Y; Chen X; Li J; Shen M
Front Med (Lausanne); 2020; 7():543290. PubMed ID: 33425930
[No Abstract] [Full Text] [Related]
2. Health state utility values in patients with Ankylosing Spondylitis: a systematic review and meta-analysis.
Feng J; Zhang K; Dou L; Shi Z; Chen G; Li S
Qual Life Res; 2024 Jun; ():. PubMed ID: 38824212
[TBL] [Abstract][Full Text] [Related]
3. Utility Scores for Risk-Reducing Mastectomy and Risk-Reducing Salpingo-Oophorectomy: Mapping to EQ-5D.
Oxley SG; Wei X; Sideris M; Blyuss O; Kalra A; Sia JJY; Ganesan S; Fierheller CT; Sun L; Sadique Z; Jin H; Manchanda R; Legood R
Cancers (Basel); 2024 Mar; 16(7):. PubMed ID: 38611036
[TBL] [Abstract][Full Text] [Related]
4. Health state utility values for children and adolescents with type 1 diabetes: A systematic review and meta-analysis.
Xie S; Li M; Chen X; Guo W; Liu X; Yang K; Wu J
Diabet Med; 2024 Jan; 41(1):e15251. PubMed ID: 37915225
[TBL] [Abstract][Full Text] [Related]
5. Health-related quality of life in patients with conditions affecting the hand: meta-analysis.
Geoghegan L; Carolina M; French J; Harrison CJ; Rodrigues JN
Br J Surg; 2024 Apr; 111(4):. PubMed ID: 38593043
[TBL] [Abstract][Full Text] [Related]
6. Total IgE as a Marker for Chronic Spontaneous Urticaria.
Altrichter S; Fok JS; Jiao Q; Kolkhir P; Pyatilova P; Romero SM; Scheffel J; Siebenhaar F; Steinert C; Terhorst-Molawi D; Xiang YK; Church MK; Maurer M
Allergy Asthma Immunol Res; 2021 Mar; 13(2):206-218. PubMed ID: 33474856
[TBL] [Abstract][Full Text] [Related]
7. Predictors of treatment response in chronic spontaneous urticaria.
Fok JS; Kolkhir P; Church MK; Maurer M
Allergy; 2021 Oct; 76(10):2965-2981. PubMed ID: 33539587
[TBL] [Abstract][Full Text] [Related]
8. Omalizumab in chronic inducible urticaria: A real-life study of efficacy, safety, predictors of treatment outcome and time to response.
Yu M; Terhorst-Molawi D; Altrichter S; Hawro T; Chen YD; Liu B; Song XT; Zhao ZT; Maurer M
Clin Exp Allergy; 2021 May; 51(5):730-734. PubMed ID: 33522024
[No Abstract] [Full Text] [Related]
9. Self-administration of omalizumab: why not? A literature review and expert opinion.
Menzella F; Ferrari E; Ferrucci SM; Lombardi E; Alfano S; Bonavita O; Morini P; Rizzi A; Matucci A
Expert Opin Biol Ther; 2021 Apr; 21(4):499-507. PubMed ID: 33504237
[No Abstract] [Full Text] [Related]
10. CME suggestions for pediatricians, allergists, and dermatologists, directed by an online survey on urticaria knowledge.
Pozo-Beltrán CF; Larenas-Linnemann D; Arteche JDC
Allergol Immunopathol (Madr); 2021; 49(1):87-94. PubMed ID: 33528934
[TBL] [Abstract][Full Text] [Related]
11. Omalizumab treatment and outcomes in Chinese patients with chronic spontaneous urticaria, chronic inducible urticaria, or both.
Chen Y; Yu M; Huang X; Tu P; Shi P; Maurer M; Zhao Z
World Allergy Organ J; 2021 Jan; 14(1):100501. PubMed ID: 33510832
[TBL] [Abstract][Full Text] [Related]
12. Recalcitrant chronic urticaria treated with dupilumab: Report of two instances refractory to H1-antihistamines, omalizumab and cyclosporine and brief literature review.
Errichetti E; Stinco G
Dermatol Ther; 2021 Mar; 34(2):e14821. PubMed ID: 33506984
[No Abstract] [Full Text] [Related]
13. Biomarkers of chronic spontaneous urticaria and their clinical implications.
Asero R; Cugno M
Expert Rev Clin Immunol; 2021 Mar; 17(3):247-254. PubMed ID: 33496195
[No Abstract] [Full Text] [Related]
14. High waist circumference rather than high body mass index may be a predictive risk factor for the longer disease duration of chronic spontaneous urticaria.
Kim YH; Do Han K; Bang CH; Lee JH; Lee JY; Park YG; Park YM
Sci Rep; 2021 Jan; 11(1):1875. PubMed ID: 33479357
[TBL] [Abstract][Full Text] [Related]
15. Long-term dupilumab treatment for chronic refractory generalized prurigo nodularis: A retrospective cohort study.
Georgakopoulos JR; Croitoru D; Felfeli T; Alhusayen R; Lansang P; Shear NH; Yeung J; Walsh S
J Am Acad Dermatol; 2021 Oct; 85(4):1049-1051. PubMed ID: 33617911
[No Abstract] [Full Text] [Related]
16. Management of Pediatric Chronic Spontaneous Urticaria: A Review of Current Evidence and Guidelines.
Chang J; Cattelan L; Ben-Shoshan M; Le M; Netchiporouk E
J Asthma Allergy; 2021; 14():187-199. PubMed ID: 33727832
[TBL] [Abstract][Full Text] [Related]
17. Quality Appraisal in Systematic Literature Reviews of Studies Eliciting Health State Utility Values: Conceptual Considerations.
Muchadeyi MT; Hernandez-Villafuerte K; Di Tanna GL; Eckford RD; Feng Y; Meregaglia M; Peasgood T; Petrou S; Ubels J; Schlander M
Pharmacoeconomics; 2024 Jul; 42(7):767-782. PubMed ID: 38551803
[TBL] [Abstract][Full Text] [Related]
18. Estimation of health utility values for alopecia areata.
Aggio D; Dixon C; Law EH; Randall R; Price T; Lloyd A
Qual Life Res; 2024 Jun; 33(6):1581-1592. PubMed ID: 38551802
[TBL] [Abstract][Full Text] [Related]
19. Quality appraisal for systematic literature reviews of health state utility values: a descriptive analysis.
Muchadeyi MT; Hernandez-Villafuerte K; Schlander M
BMC Med Res Methodol; 2022 Nov; 22(1):303. PubMed ID: 36434521
[TBL] [Abstract][Full Text] [Related]
20. A Systematic Literature Review of Economic Evaluations and Cost Studies of the Treatment of Psoriasis, Atopic Dermatitis, and Chronic Urticaria.
Igarashi A; Yuasa A; Yonemoto N; Kamei K; LoPresti M; Murofushi T; Ikeda S
Dermatol Ther (Heidelb); 2022 Aug; 12(8):1729-1751. PubMed ID: 35909186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
